Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Blessing N. Marandure, Samson Mhizha & Amanda Wilson. (2023) “Spice Was Made, by the Devil Himself”: A Thematic Analysis of the Experience of an Addiction to Synthetic Cannabinoids. Journal of Psychoactive Drugs 55:3, pages 321-329.
Read now
Read now
Honor Sibthorp Protts, Stephen Sharman & Amanda Roberts. (2023) The challenges of comorbidities: a qualitative analysis of substance use disorders and offending behaviour within homelessness in the UK. Journal of Social Distress and Homelessness 0:0, pages 1-14.
Read now
Read now
M. Adley, A. M. Atkinson & H. R. Sumnall. (2023) Including the multiply excluded: a mixed methods study exploring intragroup stigma towards people who use synthetic cannabinoid receptor agonists. Drugs: Education, Prevention and Policy 30:3, pages 312-324.
Read now
Read now
Thomas Coombs, Amor Abdelkader, Tilak Ginige, Patrick Van Calster & Sulaf Assi. (2023) Understanding synthetic drug analogues among the homeless population from the perspectives of the public: thematic analysis of Twitter data. Journal of Substance Use 0:0, pages 1-8.
Read now
Read now
Liviu Alexandrescu & Jack Spicer. (2023) The stigma-vulnerability nexus and the framing of drug problems. Drugs: Education, Prevention and Policy 30:1, pages 6-16.
Read now
Read now
Mariya Andreeva, Sophie Audette-Chapdelaine & Magaly Brodeur. (2022) Gambling-Related completed suicides: a scoping review. Addiction Research & Theory 30:6, pages 391-402.
Read now
Read now
Fiona Hutton. (2022) The co-production of shifting intoxications: synthetic cannabinoids, stigma, risk and harm. Drugs: Education, Prevention and Policy 29:4, pages 415-425.
Read now
Read now
Articles from other publishers (19)
Thomas Coombs, Amor Abdelkader, Tilak Ginige, Patrick Van Calster, Matthew Harper, Dhiya Al-Jumeily & Sulaf Assi. (2024) Understanding drug use patterns among the homeless population: A systematic review of quantitative studies. Emerging Trends in Drugs, Addictions, and Health 4, pages 100059.
Crossref
Crossref
Andrew M. Brandon, Steven R. Baginski, Caroline Peet, Pat Dugard, Henrik Green, Oliver B. Sutcliffe, Niamh Nic Daéid, Lorna A. Nisbet, Kevin D. Read & Craig McKenzie. (2023)
Log D
7.4
and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity
. Drug Testing and Analysis.
Crossref
Crossref
Sam Craft, Alice Austin, Tom Tooth, Catherine Glover, Tina Garrett, Ian S Blagbrough, Peter Sunderland, Christopher R Pudney & Tom P Freeman. (2023) Synthetic cannabinoid use in an adult male prison in the UK. International Journal of Drug Policy 122, pages 104219.
Crossref
Crossref
Jan van Amsterdam, Nicholas Burgess & Wim van den Brink. (2023) Legal Approaches to New Psychoactive Substances: First Empirical Findings. European Addiction Research, pages 1-10.
Crossref
Crossref
Svetlana SKOBEEVA & John G. FLETCHER. (2023) Synthetic cannabinoid receptor agonists (Spice): the problem they represent and a chemometric solution. Minerva Forensic Medicine 143:1.
Crossref
Crossref
Thomas Coombs, Tilak Ginige, Patrick Van Calster, Amor Abdelkader, Ornella Corazza & Sulaf Assi. (2023) New Psychoactive Substances in the Homeless Population: A Cross-Sectional Study in the United Kingdom. International Journal of Mental Health and Addiction.
Crossref
Crossref
Alane Celeste-Villalvir, Cathy Crouch, Laura Witte, Angela M. Heads, Michael Weaver, Joy M. Schmitz, Frances Isbell & Vanessa Schick. (2023) Assessing Stage of Change and Harm Reduction Strategies for Synthetic Cannabinoid Use Among Individuals Experiencing Homelessness in Houston, Texas. Journal of Drug Issues, pages 002204262311612.
Crossref
Crossref
Alice Seywright, Alexander F. D Irvine, Denise A McKeown, Fiona M Wylie & Hazel J Torrance. (2022) Synthetic Cannabinoid Receptor Agonists in Postmortem Casework in Scotland. Journal of Analytical Toxicology 46:9, pages 1066-1072.
Crossref
Crossref
Vasco Orazietti, Giuseppe Basile, Raffaele Giorgetti & Arianna Giorgetti. (2022) Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving. Frontiers in Psychiatry 13.
Crossref
Crossref
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, Fabiano Reniero, Claude Guillou & Christophe P. Stove. (2022) Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists. Drug Testing and Analysis 14:9, pages 1565-1575.
Crossref
Crossref
Pruntha YoganathanHugh ClaridgeLucy ChesterAmir EnglundNicola J. KalkCaroline S. Copeland. (2022) Synthetic Cannabinoid-Related Deaths in England, 2012–2019. Cannabis and Cannabinoid Research 7:4, pages 516-525.
Crossref
Crossref
Orion Santangelo, Julie Marie Baldwin & John Stogner. (2022) Does cannabis testing in the military drive synthetic cannabinoid use? Self-reported use motivations among justice-involved veterans. International Journal of Drug Policy 106, pages 103756.
Crossref
Crossref
Robert Kronstrand, Caitlyn Norman, Svante Vikingsson, Anoek Biemans, Bryan Valencia Crespo, Darren Edwards, Daniel Fletcher, Nicolas Gilbert, Mattias Persson, Robert Reid, Olga Semenova, Faisal Al Teneiji, Xiongyu Wu, Johan Dahlén, Niamh NicDaéid, Fuad Tarbah, Oliver B. Sutcliffe, Craig McKenzie & Henrik Gréen. (2021) The metabolism of the synthetic cannabinoids ADB‐BUTINACA and ADB‐4en‐PINACA and their detection in forensic toxicology casework and infused papers seized in prisons. Drug Testing and Analysis 14:4, pages 634-652.
Crossref
Crossref
Adeline M. Nyamathi, Lillian Gelberg, Darlene Lee, Nicholas Arce, Alexandria Patten-Jones, Kartik Yadav, Maniyah Goodwine, Mitra Alikhani, Maritas Yao, Alicia H. Chang & Benissa E. Salem. (2022) Perceptions of Homeless Adults and Their Providers on Coping With the Impact of COVID-19 Pandemic on Mental Health, Substance Use, and Harm Reduction Services. Global Qualitative Nursing Research 9, pages 233339362211087.
Crossref
Crossref
A.-L. Pélissier-Alicot. 2022. Cannabis and the Developing Brain. Cannabis and the Developing Brain
243
258
.
Adrian A Deen, Hugh Claridge, Richard D TrebleHilary J Hamnett & Caroline S Copeland. (2021) Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016. Journal of Psychopharmacology 35:11, pages 1315-1323.
Crossref
Crossref
Rob Ralphs, Paul Gray & Oliver B. Sutcliffe. (2021) The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population: Markets, content and user harms. International Journal of Drug Policy 97, pages 103305.
Crossref
Crossref
Kenichi Tamama. 2021.
191
214
.
Stephen Campbell & Rob Poole. (2020) Editorial: Disorderly street users of novel psychoactive substances: What might help?. Criminal Behaviour and Mental Health 30:2-3, pages 53-58.
Crossref
Crossref